^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SeekInCure®

    Company:
    SeekIn
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    The first-in-class blood-based pan-cancer recurrence monitoring test. SeekInCure is applied to monitoring cancer recurrence and risk evaluation for post-op cancer patients. By monitoring the variation of cancer genome in cell-free DNA (cfDNA) of post-op cancer patients continually, combined with plasma protein markers, equipping big data and artificial intelligence, it generates cancer recurrence index (CRI).
    Cancer:
    Pancreatic Cancer
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    11/28/22
    PC
    -
    CE